Co-delivery of hesperetin enhanced bicalutamide induced apoptosis by exploiting mitochondrial membrane potential via polymeric nanoparticles in a PC-3 cell line-Reference-Cited by-同舟云学术

Co-delivery of hesperetin enhanced bicalutamide induced apoptosis by exploiting mitochondrial membrane potential via polymeric nanoparticles in a PC-3 cell line

Published:2016 Issue:7 Volume:6 Page:5925-5935
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Arya Abhishek¹²³⁴⁵,Khandelwal Kiran¹²³⁴⁶,Ahmad Hafsa¹²³⁴,Laxman Tulsankar Sachin⁵⁷⁴⁸²,Sharma Komal¹²³⁴⁵,Mittapelly Naresh¹²³⁴⁵,Agrawal Satish¹²³⁴⁵,Bhatta Rabi S.⁸²³⁴,Dwivedi Anil K.¹²³⁴

Affiliation:

1. Pharmaceutics Division

2. CSIR-Central Drug Research Institute

3. Lucknow-226031

4. India

5. Academy of Scientific & Innovative Research

6. Jawaharlal Nehru University

7. Chennai-600113

8. Pharmacokinetics and Metabolism

Abstract

In this research, we reported the co-delivery of anti-androgen drug Bicalutamide with Hesperetin in chitosan coated polycaprolactone nanoparticles to increase their therapeutic efficacy against an androgen independent prostate cancer cell lines.

Funder

Central Drug Research Institute

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/RA/C5RA23067E

Reference51 articles.

1. Screening for prostate cancer

2. Cancer statistics, 2015

3. http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm133082.htm, 2015

4. Micellar Delivery of Bicalutamide and Embelin for Treating Prostate Cancer

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Cancer Treatment: Exploring the Latest Breakthroughs in Bicalutamide Delivery and Co-Delivery Nanoformulations for Cancer Therapy;Journal of Drug Delivery Science and Technology;2024-09

2. Multifunctional nanocarrier-mediated codelivery for targeting and treatment of prostate cancer;Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy;2024

3. Co-delivery of Anticancer Drugs Using Polymer-Based Nanomedicines for Lung and Prostate Cancer Therapy;Interaction of Nanomaterials With Living Cells;2023

4. Advancements in clinical translation of flavonoid nanoparticles for cancer treatment;OpenNano;2022-11

5. Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer;Drug Resistance Updates;2022-09